Avita Medical Ltd (RCEL)

18.21
-0.18(-0.98%)
  • Volume:
    49,002
  • Bid/Ask:
    16.52/21.99
  • Day's Range:
    18.12 - 18.43

RCEL Overview

Prev. Close
18.39
Day's Range
18.12-18.43
Revenue
29.23M
Open
18.31
52 wk Range
16.52-28.49
EPS
-1.19
Volume
49,002
Market Cap
451.7M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
139,314
P/E Ratio
-
Beta
1.02
1-Year Change
-24.28%
Shares Outstanding
124,744,360
Next Earnings Date
Nov 16, 2021
What is your sentiment on Avita Medical Ltd?
or
Market is currently closed. Voting is open during market hours.

Avita Medical Ltd News

  • Avita Medical Earnings, Revenue Beat in Q2
    • ByInvesting.com-

    Investing.com - Avita Medical (NASDAQ:RCEL) reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations. Avita Medical...

  • Avita Medical Earnings, Revenue Beat in Q1
    • ByInvesting.com-

    Investing.com - Avita Medical (NASDAQ:RCEL) reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations. Avita Medical...

  • Avita Medical Earnings, Revenue Beat in Q4
    • ByInvesting.com-

    Investing.com - Avita Medical (NASDAQ:RCEL) reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations. Avita Medical...

Avita Medical Ltd Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellSellSell
Technical IndicatorsStrong SellSellStrong BuyStrong SellStrong Sell
SummaryStrong SellSellNeutralStrong SellStrong Sell

Avita Medical Ltd Company Profile

Avita Medical Ltd Company Profile

Employees
0

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company’s patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient’s own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient’s own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.

Read More
  • FDA approved for under 18s now. This will be $40 before long.
    0
    • RDGL 0.125 By 1/16/2021 FDA will provide a final decision to grant or deny their request for breakthrough designation.
      0
      • this stock will soon be $15.
        0
        • a great product and they will most likely be bought by a large company for huge money.
          0
        • When will this buyout happen, after most invester have lost there faith ?
          1
        • good call
          0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.